STA
CMD

Summit Trail Advisors’s Cantel Medical Corporation CMD Stock Holding History

Summit Trail Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,396
Closed -$151K – 1899
2017
Q4 		$151K Buy
+1,396
New +$139K 0.02% 513

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Summit Trail Advisors's CMD Position: Q1 2018 in Review

Summit Trail Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 1,396 shares — an estimated $151K sold.

Summit Trail Advisors first reported a position in CMD in Q4 2017 and held it in 1 quarter. The position peaked at $151K in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

  • Summit Trail Advisors reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 1,396 Cantel Medical Corporation shares in Q1 2018, an estimated $151K.
  • Summit Trail Advisors first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's Cantel Medical Corporation position peaked at $151K in Q4 2017.
  • 270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.